Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer

PURPOSE: To compare clinically significant prostate cancer (csPCa) detection rates between magnetic resonance imaging (MRI)–transrectal ultrasound (TRUS) fusion-guided prostate biopsy (FGB) and direct in-bore MRI-guided biopsy (MRGB). METHODS: We performed a comparison of csPCa detection rates betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Venderink, Wulphert, van der Leest, Marloes, van Luijtelaar, Annemarijke, van de Ven, Wendy J. M., Fütterer, Jurgen J., Sedelaar, J. P. Michiel, Huisman, Henkjan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693982/
https://www.ncbi.nlm.nih.gov/pubmed/28871396
http://dx.doi.org/10.1007/s00345-017-2085-6

Ejemplares similares

Ejemplares similares